Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
South Africa: Almost half of injecting drug users surveyed have contracted Hepatitis C

Close to half of injecting drug users surveyed in South Africa are living with the potentially deadly Hepatitis C virus, a new study has found. But a drug that could cure them, and that is used in several countries, remains unavailable in South Africa.

Published
15 August 2018
From
Bhekisisa
HIV and chronic HCV co-infection prevalence in England highest among MSM

Men who have sex with men (MSM) make up the majority of people with chronic hepatitis C virus (HCV) who have co-infection with HIV, according to data

Published
15 August 2018
By
Michael Carter
Fewer Australians are dying from hepatitis C, but thousands are still missing out on treatment

The number of Australians dying from liver failure and liver cancer related to hepatitis C has dropped by 20 per cent in just two years, according to preliminary data released today by The Kirby Institute.

Published
13 August 2018
From
ABC News
Fighting hepatitis C demands more than cheap drugs

Providing cheap drugs against the hepatitis C virus (HCV) has had limited success in fighting the disease in South-East Asia where poor health services and stigma surrounding the infection are significant barriers, says a new survey.

Published
30 July 2018
From
SciDev.Net
Supervised drug consumption sites offer opportunities for HCV testing and treatment

Most supervised drug consumption facilities offer hepatitis C virus (HCV) testing and referrals, but very few offer treatment, indicating that they could potentially play a greater role in

Published
27 July 2018
By
Liz Highleyman
Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

Hologic, Inc. announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the U.K. government), to increase affordable access to molecular testing for HIV, hepatitis B and C (HBV and HCV) and human papillomavirus (HPV) in nearly 50 nations around the world. These countries, primarily across Africa and Southeast Asia, make up 90 percent of the HIV disease burden globally.

Published
25 July 2018
From
Hologic press release
Unprecedented hepatitis C infection rates seen in gay men in Amsterdam PrEP programme

Regular hepatitis C testing among the HIV-negative gay men and other men who have sex with men (MSM) participating in the Amsterdam pre-exposure prophylaxis (PrEP)

Published
25 July 2018
By
Gus Cairns
The 2018 Pipeline Report

Welcome to the 2018 Pipeline Report, Treatment Action Group’s annual review of therapeutics, diagnostics, vaccines, and preventive technologies in development for HIV, hepatitis C virus (HCV), and tuberculosis, along with immune-based and gene therapies and research toward a cure for HIV.

Published
24 July 2018
From
TAG
FIND and DNDi support Malaysian MOH to simplify and decentralize HCV screening & treatment

FIND and the DNDi will partner to generate evidence that will support policy change and scale up of hepatitis C diagnosis and treatment. This work, announced at the AIDS 2018 conference in Amsterdam and ahead of World Hepatitis Day 2018, is being conducted in collaboration with the Ministry of Health in Malaysia with a view to overcoming barriers to diagnosis and treatment.

Published
23 July 2018
From
Eurekalert Inf Dis
France: people who inject drugs often given cheaper, less effective, hepatitis C medication

People living with HIV and hepatitis C (HCV) who have a history of injecting drug use are being offered less effective, but cheaper, HCV medication than other people with HIV/HCV co-infections, new research from France finds.

Published
17 July 2018
From
AVERT
← First12345...190Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.